Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Nasal and Pulmonary Nitric Oxide Output in COVID-19 Infection

NCT04728919 is registered in ClinicalTrials.gov with Tampere University Hospital as lead sponsor.

NCT NCT04728919
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04728919 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Nasal and Pulmonary Nitric Oxide Output in COVID-19 Infection
Lead sponsor
Tampere University Hospital
Phase
Observational
Overall status
Unknown status
Start date
January 15, 2021
Completion date
January 15, 2024
Enrollment
82 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19, sars-cov-2 infection